MedPath
NMPA Approval

Brimonidine Tartrate Eye Drops

国药准字H20249123

October 22, 2024

Drug Information

酒石酸溴莫尼定滴眼液

眼用制剂

0.2%(5ml:10mg,按C₁₁H₁₀BrN₅·C₄H₆O₆计)

化学药品

October 22, 2024

Company Information

Applicant Company

苏州市吴中区郭巷街道尹中南路1858号

Manufacturing Company

苏州市吴中区郭巷街道尹中南路1858号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

酒石酸溴莫尼定滴眼液 - NMPA 批准文号 | MedPath